16829 Risk of major cardiovascular events with interleukin-12/23 inhibition compared with tumor necrosis factor α in patients with psoriasis: Pharmacovigilance analysis within a large Midwestern US patient population from the RADAR program

Authors :: Nari Lee
Yasmeen Ali
S. Amin
Dennis P. West
Beatrice Nardone
Jennifer J. Parker
Ahmad Amin
Sara Majewski
Source :: Journal of the American Academy of Dermatology. 83:AB186
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Dermatology
medicine.disease
Patient population
Psoriasis
Internal medicine
Pharmacovigilance
medicine
Interleukin 12
In patient
business
Tumor necrosis factor α

Tools